Turn Therapeutics Inc. Releases Updated Investor Presentation

What Happened

• On July 28, 2026, Turn Therapeutics Inc. filed a Form 8-K reporting a Regulation FD disclosure and furnished an updated investor presentation. The presentation is attached to the filing as Exhibit 99.1. The report also includes the cover page interactive data file (Exhibit 104) embedded in the Inline XBRL document.

Key Details

• Filing date: July 28, 2026 (Form 8-K).
• Item reported: 7.01 — Regulation FD Disclosure.
• Exhibit furnished: 99.1 — Investor Presentation dated July 28, 2026.
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL).

Why It Matters

• The company used a Regulation FD filing to distribute an updated investor presentation, ensuring the information is broadly and fairly disclosed to all investors. Retail investors should review Exhibit 99.1 directly to see any disclosures about strategy, clinical pipeline, milestones, or financial information contained in the presentation. This 8-K did not report earnings, executive changes, mergers, or other separate material events.